Key Developments

On February 15, 2024, Johnson & Johnson MedTech, a Johnson & Johnson Services, Inc. company, announced that it had launched TECNIS PureSee intraocular lens in Europe, Middle East, and Africa. TECNIS PureSee intraocular lens features a proprietary, purely refractive design that delivers uninterrupted, high-quality, vision with high best-in-category contrast and low-light performance, comparable to a monofocal intraocular lens.
In August 2023, Carl Zeiss Meditec, a healthcare company, announced that it had showcased its new ophthalmic innovations within the cataract and corneal refractive workflows at the European Society of Cataract and Refractive Surgery (ESCRS) annual conference from 8 to 12 September, 2023, in Austria, Europe
In October 2021, Ocumetics Technology Corp., a Canada-based research and ophthalmic products development company, announced the phase of a clinical trial program for Bionic Lens. It is an expandable intraocular lens that fits in the lens compartment of the eye, which eliminates the need for corrective lenses. The mechanism of the lens involves re-establishment of the natural kinetics of the eye muscles for facilitating the eye’s ability to promote better focus from distance to near and very near range.
In January 2020, STAAR SURGICAL, a developer, manufacturer, and marketer of implantable lenses, announced that it had received CE Mark approval for the use of its Intraocular lens as a supplemental or “piggyback” lens in post-cataract IOL surgery patients (pseudophakics). EVO/EVO+ and VISIAN Implantable Collamer Lenses for myopia and hyperopia, and EVO/EVO+ and VISIAN Toric Implantable Collamer Lenses for myopia and hyperopia with astigmatism.